Cargando…

FXYD6: a novel therapeutic target toward hepatocellular carcinoma

FXYD6, FXYD domain containing ion transport regulator 6, has been reported to affect the activity of Na(+)/K(+)-ATPase and be associated with mental diseases. Here, we demonstrate that FXYD6 is up-regulated in hepatocellular carcinoma (HCC) and enhances the migration and proliferation of HCC cells....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Qian, Chen, Xiongfei, Duan, Hongxia, Wang, Zhaoqing, Feng, Jing, Yang, Dongling, Song, Lina, Zhou, Ningxin, Yan, Xiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085285/ https://www.ncbi.nlm.nih.gov/pubmed/24715268 http://dx.doi.org/10.1007/s13238-014-0045-0

Ejemplares similares

FXYD6 is a new biomarker of cholangiocarcinoma
por: CHEN, XIONGFEI, et al.
Publicado: (2014)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021)

Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma
por: Wang, Li-Juan, et al.
Publicado: (2018)

FXYD6 promotes thermal nociception by regulating TRPV1
por: Luo, Hao, et al.
Publicado: (2021)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)

Expression and clinical significance of FXYD3 in endometrial cancer
por: LI, YIFEI, et al.
Publicado: (2014)

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport
por: Arystarkhova, Elena, et al.
Publicado: (2017)

Displacement of Native FXYD Protein From Na(+)/K(+)-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
por: Liu, Chia-Chi, et al.
Publicado: (2022)

FXYD proteins and sodium pump regulatory mechanisms
por: Yap, John Q., et al.
Publicado: (2021)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2013)

Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2010)

Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma
por: Hsu, I-Ling, et al.
Publicado: (2016)

FXYD-3 expression in relation to local recurrence of rectal cancer
por: Loftas, Per, et al.
Publicado: (2016)

FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease
por: Lubarski Gotliv, Irina
Publicado: (2016)

FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
por: Raman, Pichai, et al.
Publicado: (2015)

FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
por: Yonekura, Satoru, et al.
Publicado: (2022)

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury
por: Brazee, Patricia L., et al.
Publicado: (2017)

Expression mode and prognostic value of FXYD family members in colon cancer
por: Jin, Ming, et al.
Publicado: (2021)

Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues
por: Cuomo, Mariella, et al.
Publicado: (2022)

Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice
por: Zeng, Qiqun, et al.
Publicado: (2014)

Renal Mg handling, FXYD2 and the central role of the Na,K‐ATPase
por: Mayan, Haim, et al.
Publicado: (2018)

FXYD protein isoforms differentially modulate human Na/K pump function
por: Meyer, Dylan J., et al.
Publicado: (2020)

Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na(+),K(+)-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells
por: Jan, Vid, et al.
Publicado: (2021)

Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis
por: Luo, Yongting, et al.
Publicado: (2017)

CD146 Deletion in the Nervous System Impairs Appetite, Locomotor Activity and Spatial Learning in Mice
por: Tu, Tao, et al.
Publicado: (2013)

CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancer
por: ZHANG, HAOFENG, et al.
Publicado: (2013)

Fxyd5 activates the NF-κB pathway and is involved in chondrocytes inflammation and extracellular matrix degradation
por: Song, Lulu, et al.
Publicado: (2022)

Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Zedan, et al.
Publicado: (2022)

The signalling receptor MCAM coordinates apical-basal polarity and planar cell polarity during morphogenesis
por: Gao, Qian, et al.
Publicado: (2017)

CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis
por: Yan, Huiwen, et al.
Publicado: (2017)

MMP8 increases tongue carcinoma cell–cell adhesion and diminishes migration via cleavage of anti-adhesive FXYD5
por: Juurikka, K., et al.
Publicado: (2021)

FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer
por: Luo, Wen, et al.
Publicado: (2021)

Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression
por: Vallois, David, et al.
Publicado: (2014)

Fxyd2 regulates Aδ- and C-fiber mechanosensitivity and is required for the maintenance of neuropathic pain
por: Ventéo, Stéphanie, et al.
Publicado: (2016)

KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation
por: Ma, Yu‐Shui, et al.
Publicado: (2021)

FXYD domain containing ion transport regulator 5 (FXYD5) silencing promotes cell viability and alleviates inflammatory response in cerulein-induced AR42J cells by blocking JAK2/STAT3 signaling pathway
por: Ding, Licheng, et al.
Publicado: (2022)

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression
Publicado: (2014)

Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia
por: Chaumette, Boris, et al.
Publicado: (2018)

FXYD8, a Novel Regulator of Renal Na(+)/K(+)-ATPase in the Euryhaline Teleost, Tetraodon nigroviridis
por: Wang, Pei-Jen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ube9gt8r9s8hi5v9i0vnf2vee